{
    "nct_id": "NCT03169023",
    "official_title": "Scale Down: A Randomized, Controlled Weight Management Intervention for Women With Endometrial Cancer",
    "inclusion_criteria": "* Female women 18 years of age or older and with biopsy-proven endometrial cancer.\n* BMI greater than or equal to 30 kg/m^2.\n* Must be able to read and speak English.\n* All patients must be informed of the investigational nature of this study and must sign and give written informed consent for Aim 1 study activities in accordance with institutional and federal guidelines.\n* Has completed prior surgical management and adjuvant endometrial cancer treatment, if adjuvant treatment is indicated, prior to starting Aim 1.\n* Is not receiving concurrent cytotoxic chemotherapy and/or radiation therapy at time of enrollment AND, if randomized, is not anticipated that the participant will need to receive concurrent cytotoxic chemotherapy and/or radiation therapy at any time during the Aim 1 intervention\n* Patients with BMI greater than or equal to 30 kg/m^2 who are undergoing hormonal treatment of endometrial cancer.\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2\n* Life expectancy of at least one year\n* Must have a phone capable of receiving text messages.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Females under the age of 18 years\n* BMI less than 30 kg/m^2\n* Must not be participating in another formal weight loss program.\n* Must not have any other clinically significant medical disease or condition that, in the Investigator's opinion, may interfere with protocol adherence or a participant's ability to give informed consent.\n* For participants who are randomized in Aim 1:\n\n  * No uncontrolled serious medical or psychiatric condition(s) that would affect the patient's ability to participate in the interventional study, e.g., uncontrolled hypertension, symptomatic cardiac disease, or severe/uncontrolled depression as indicated by a previously completed Patient Health Questionnaire (PHQ-9) score >9 (Kroenke)\n  * No diagnoses of any other invasive malignancy other than endometrial cancer or non-melanoma skin cancer which required active treatment currently or within the last 2 years.",
    "miscellaneous_criteria": ""
}